alexa
Reach Us +1-217-403-9671
Quality-by-design Approach To Analytical Method Development | 7478
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Quality-by-design approach to analytical method development

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Yogita Prajapati

Posters: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.007

Abstract
Quality-by-design was first described by Joseph M. Juran, is a systematic approach to drug development, which begins with pre-defined objectives, and uses science and risk management approaches to gain product and process understanding and ultimately process control. The FDA has recently begun to advocate the QbD methodology for the pharmaceutical sector. More companies in the pharmaceutical industry today are in the need of adopting the principles of Quality-by-design (QbD) to the development of analytical methods in addition to the development of manufacturing processes. As such, both industry and regulators recognize the benefits of adopting a QbD approach to drug-product development and manufacture, with key concepts described in the International Conference on Harmonization (ICH) guidelines, Q8 (R1) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. Drug development using the principles of QbD can be introduced as two key concepts that further aid in implementation. The first concept is the ?design space? that generally involves the identification of the critical attributes for the input materials, the process, and the final product. Another important concept is that of the ?control strategy? which is to ensure the final quality of the product. Some of the concepts are more applicable than others, and some have been advocated by many method development experts for some time, but modern technology has created an opportunity to revisit strategies for creation of chromatographic methods in particular, and it is certainly interesting to investigate the new opportunities in the context of Quality by Design. The ultimate goal is to highlight the QbD concepts and terminology can be applied to analytical methods and to suggest how adoption of a QbD approach might be used to develop more robust analytical methods and effective control systems.
Biography
Top